Anthony Stein
City of Hope Medical Center · City of Hope National Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anthony Stein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:37 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05222984 · Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With VenetoclaxCity of Hope Medical Center · active not recruiting · Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia · principal investigator
- Ph2NCT02094794 · Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AMLCity of Hope Medical Center · active not recruiting · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) · principal investigator
- Ph1NCT00641030 · Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesCity of Hope Medical Center · completed · Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph1/Ph2NCT00540995 · Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid CancerCity of Hope Medical Center · terminated · Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) · principal investigator
- Ph2NCT00201240 · Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)National Heart, Lung, and Blood Institute (NHLBI) · completed · Leukemia, Myelocytic, Acute · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Image-guided irradiation safely intensifies HSCT regimen for refractory leukemiaR01CA195519 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2016 to 2018 · $238,425 awarded in 2018Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2008 to 2026Named on NCT05222984, NCT00641030
- Conformal Total Body and Marrow Irradiation for LeukemiaR01CA154491 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Susanta K Hui, JEFFREY Y WONG · fiscal years 2011 to 2024Named on NCT02094794
- Blood and Marrow Transplant Clinical Trials NetworkU01HL069254 · NHLBI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI Michael A Pulsipher · fiscal years 2009 to 2010Named on NCT00201240
- Random Trial of CD8 T-Cell Depletion in PBSC TransplantationU01HL069249 · NHLBI · DANA-FARBER CANCER INST · PI JOSEPH H ANTIN · fiscal years 2009 to 2010Named on NCT00201240
- Blood and Marrow Transplant Clinical Research NetworkU01HL069278 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Stephen J Forman · fiscal years 2008 to 2010Named on NCT00201240
- BMT Clinical Research Network Data Coordinating CenterU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Mary Maresca Horowitz · fiscal years 2008 to 2010Named on NCT00201240
- IL-7 FOR IMMUNE RECOVERY AFTER HEMATOPOIETIC ALLOGRAFTSU01HL069315 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI Sergio A Giralt · fiscal years 2008 to 2010Named on NCT00201240
- NHLBI Blood /Marrow Transplant Clinical Research NetworkU01HL069348 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI HILLARD M LAZARUS · fiscal years 2008 to 2010Named on NCT00201240
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:37 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia.Am J Hematol · 2017143 citationsRCR 4.1
- 49 citationsRCR 1.6
- Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.Int J Radiat Oncol Biol Phys · 201430 citationsRCR 1.3
- Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.Haematologica · 202514 citationsRCR 3.2
- Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemia.Eur J Haematol · 20213 citationsRCR 0.2